scholarly journals Metformin plus radiotherapy effect on diabetic patients with Non-small-cell lung carcinoma: an updated systematic review and meta-analysis

2021 ◽  
Vol 19 (4) ◽  
pp. 771-778
Author(s):  
R. Zhao ◽  
J. Xin ◽  
H. Xiao ◽  
P. Li3 ◽  
X. Zhu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
Meta Analysis ◽  
Small Cell ◽  
Diabetic Patients ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma

scholarly journals Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis

PLoS ONE ◽  
2012 ◽  
Vol 7 (3) ◽  
pp. e34100 ◽  
Author(s):  
Lou Qian Zhang ◽  
Jun Wang ◽  
Feng Jiang ◽  
Lin Xu ◽  
Fu Yin Liu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Lung Carcinoma ◽  
Prognostic Value ◽  
Small Cell Lung Carcinoma ◽  
Meta Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma

scholarly journals MALAT-1 Expression Correlates with Prognosis in Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Ran Ran ◽  
Jian-wei Jin ◽  
Wei-ping Zhang
Keyword(s):  
Systematic Review ◽  
Lung Carcinoma ◽  
Noncoding Rna ◽  
Small Cell Lung Carcinoma ◽  
Meta Analysis ◽  
Small Cell ◽  
Cochrane Library ◽  
Small Cell Lung ◽  
China National Knowledge Infrastructure ◽  
Cell Lung Carcinoma

Background. Non-small-cell lung carcinoma (abbreviated as NSCLC) progresses rapidly and lacks appropriate biological markers. Recent studies have shown that long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) has potential application value for clinically diagnosing lung carcinoma. Thus, this study conducted a systematic review and meta-analysis for assessing if MALAT-1 has a relationship to NSCLC outcome. Methods. This study conducted the search of China National Knowledge Infrastructure, China Science and Technology Journal, SinoMed, EMBASE, Cochrane library, Web of Science, Wanfang database, and PubMed from inception to September, 1, 2021. The published article about MALAT-l expression for NSCLC patients was analyzed. We used combined hazard rates under the confidence interval of 95% for examining the relationship of MALAT-l and NSCLC.Results. In this meta-analysis, we found that 10 studies were included, and MALAT-1 expressions were distinctly related to an unfavorable overall survival (HR: 2.34 (1.65, 3.33); I2 = 76%). Considering the merger’s clinical heterogeneity, for meta-analysis, we used the random-effects method. Conclusion. Overexpression of MALAT-1 showed correlations to the less effective outcome of NSCLC. MALAT-1 might be a new NSCLC prognosis marker.

Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis

2020 ◽  
Author(s):  
Michiel A. Ijsseldijk ◽  
Melina Shoni ◽  
Charles Siegert ◽  
Bastiaan Wiering ◽  
Anton K.C. van Engelenburg ◽  
...  
Keyword(s):  
Systematic Review ◽  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
Meta Analysis ◽  
Small Cell ◽  
Oncologic Outcomes ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document